LT3810633T - Junginiai - Google Patents

Junginiai

Info

Publication number
LT3810633T
LT3810633T LTEPPCT/EP2019/066819T LTEP2019066819T LT3810633T LT 3810633 T LT3810633 T LT 3810633T LT EP2019066819 T LTEP2019066819 T LT EP2019066819T LT 3810633 T LT3810633 T LT 3810633T
Authority
LT
Lithuania
Prior art keywords
compounds
Prior art date
Application number
LTEPPCT/EP2019/066819T
Other languages
English (en)
Inventor
Pamela Brown
Michael Dawson
Mona SIMONOVIC
Steven Boakes
Esther DUPERCHY
Dean Rivers
Roy LESTER
Scott Coleman
Original Assignee
Spero Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spero Therapeutics, Inc. filed Critical Spero Therapeutics, Inc.
Publication of LT3810633T publication Critical patent/LT3810633T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEPPCT/EP2019/066819T 2018-06-25 2019-06-25 Junginiai LT3810633T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862689602P 2018-06-25 2018-06-25
PCT/EP2019/066819 WO2020002325A1 (en) 2018-06-25 2019-06-25 Compounds

Publications (1)

Publication Number Publication Date
LT3810633T true LT3810633T (lt) 2024-01-10

Family

ID=67107423

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2019/066819T LT3810633T (lt) 2018-06-25 2019-06-25 Junginiai

Country Status (27)

Country Link
US (2) US11459357B2 (lt)
EP (2) EP4316504A3 (lt)
JP (1) JP7488774B2 (lt)
KR (1) KR20210054500A (lt)
CN (1) CN112789287A (lt)
AR (1) AR116663A1 (lt)
AU (1) AU2019294261B2 (lt)
BR (1) BR112020026663A2 (lt)
CA (1) CA3103158A1 (lt)
CO (1) CO2020016080A2 (lt)
DK (1) DK3810633T3 (lt)
EA (1) EA202092819A1 (lt)
FI (1) FI3810633T3 (lt)
HR (1) HRP20240028T1 (lt)
IL (1) IL279620A (lt)
LT (1) LT3810633T (lt)
MA (1) MA52946B1 (lt)
MX (1) MX2020013811A (lt)
PH (1) PH12020552240A1 (lt)
PL (1) PL3810633T3 (lt)
PT (1) PT3810633T (lt)
RS (1) RS65128B1 (lt)
SG (1) SG11202012747VA (lt)
SI (1) SI3810633T1 (lt)
TW (1) TW202019949A (lt)
WO (1) WO2020002325A1 (lt)
ZA (1) ZA202301937B (lt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015352440B2 (en) * 2014-11-26 2020-02-06 Spero Therapeutics, Inc. Compounds
RS65128B1 (sr) * 2018-06-25 2024-02-29 Spero Therapeutics Inc Jedinjenja
WO2022098950A1 (en) 2020-11-06 2022-05-12 Spero Therapeutics, Inc. Compounds

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
AU7753787A (en) 1986-08-06 1988-02-24 Jean-Luc Fauchere Production of covalent-linked conjugates from an antibiotic and a non-toxic derivative of polymyxine b
US20010021697A1 (en) 1987-09-14 2001-09-13 Henning Lowenstein Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
TW274552B (lt) 1992-05-26 1996-04-21 Hoechst Ag
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
MXPA06003573A (es) 2003-09-30 2006-08-31 Kohi Corp Composiciones y metodos para tratar quemaduras.
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US7807637B2 (en) 2006-08-11 2010-10-05 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
CA2694289C (en) 2006-08-11 2015-04-07 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
FI20085469A0 (fi) 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
US8193148B2 (en) 2008-02-08 2012-06-05 Northern Antibiotics Ltd. Short fatty acid tail polymyxin derivatives and uses thereof
US8329645B2 (en) 2008-02-08 2012-12-11 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
ES2334547B1 (es) 2008-09-10 2010-12-03 Universidad De Barcelona Compuestos peptidicos antibacterianos.
US8343912B2 (en) 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CN101851270A (zh) 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
WO2010130007A1 (en) 2009-05-14 2010-11-18 Monash University Antimicrobial compounds
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
WO2012168820A1 (en) * 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
WO2013072695A1 (en) * 2011-11-18 2013-05-23 Novacta Biosystems Limited Polymyxin derivatives
BR112015029309A2 (pt) 2013-05-22 2017-07-25 New Pharma Licence Holdings Ltd derivados de polimixina e seu uso em terapia de combinação junto com antibióticos diferentes
WO2015135976A1 (en) 2014-03-11 2015-09-17 New Pharma Licence Holdings Limited Polymyxin derivatives and their use in combination therapy together with different antibiotics
CN106414480B (zh) 2014-04-01 2020-08-04 莫纳什大学 作为抗微生物化合物的多黏菌素衍生物
AU2015352440B2 (en) 2014-11-26 2020-02-06 Spero Therapeutics, Inc. Compounds
WO2016166103A1 (en) 2015-04-13 2016-10-20 Xellia Pharmaceuticals Aps Polymyxin derivatives
AU2016331658B2 (en) 2015-09-29 2021-04-01 Monash University Antimicrobial polymyxin derivative compounds
RS65128B1 (sr) * 2018-06-25 2024-02-29 Spero Therapeutics Inc Jedinjenja
WO2020014501A1 (en) 2018-07-11 2020-01-16 Cidara Therapeutics, Inc. Compositions and methods for the treatment of bacterial infections

Also Published As

Publication number Publication date
EP4316504A3 (en) 2024-04-17
EP3810633A1 (en) 2021-04-28
DK3810633T3 (da) 2024-01-15
EA202092819A1 (ru) 2021-05-21
FI3810633T3 (fi) 2024-02-09
BR112020026663A2 (pt) 2021-03-23
AU2019294261A1 (en) 2021-02-04
MA52946B1 (fr) 2024-03-29
SI3810633T1 (sl) 2024-04-30
EP3810633B1 (en) 2023-12-13
JP7488774B2 (ja) 2024-05-22
US20210246169A1 (en) 2021-08-12
US11459357B2 (en) 2022-10-04
JP2021528449A (ja) 2021-10-21
MX2020013811A (es) 2021-03-09
CA3103158A1 (en) 2020-01-02
HRP20240028T1 (hr) 2024-03-29
TW202019949A (zh) 2020-06-01
MA52946A (fr) 2021-04-28
CN112789287A (zh) 2021-05-11
AU2019294261B2 (en) 2024-02-29
PH12020552240A1 (en) 2021-08-16
CO2020016080A2 (es) 2021-01-18
AR116663A1 (es) 2021-06-02
KR20210054500A (ko) 2021-05-13
US20230012121A1 (en) 2023-01-12
IL279620A (en) 2021-03-01
PL3810633T3 (pl) 2024-04-08
PT3810633T (pt) 2024-02-19
SG11202012747VA (en) 2021-01-28
RS65128B1 (sr) 2024-02-29
ZA202301937B (en) 2023-09-27
WO2020002325A1 (en) 2020-01-02
EP4316504A2 (en) 2024-02-07

Similar Documents

Publication Publication Date Title
GB201805174D0 (en) Compounds
GB202108469D0 (en) Compounds
GB201807924D0 (en) Compounds
IL279620A (en) compounds
GB201814151D0 (en) Compounds
GB201808093D0 (en) Compounds
GB201809102D0 (en) Compounds
GB201817083D0 (en) Compounds
GB201803340D0 (en) Compounds
GB201820887D0 (en) Compounds
GB201818649D0 (en) Compounds
GB201818651D0 (en) Compounds
GB201814167D0 (en) Compounds
GB201801128D0 (en) Compounds
GB201801130D0 (en) Compounds
GB201820989D0 (en) Compounds
GB201819102D0 (en) Compounds
GB201818927D0 (en) Compounds
GB201818698D0 (en) Compounds
GB201818410D0 (en) Compounds
GB201817342D0 (en) Compounds
GB201817291D0 (en) Compounds
GB201817292D0 (en) Compounds
GB201817303D0 (en) Compounds
GB201816998D0 (en) Compounds